Annovis Bio, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Annovis Bio, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $4.94M.
- Annovis Bio, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $5.03M, a 41.35% decline year-over-year.
- Annovis Bio, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $3.88M.
- Annovis Bio, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $8.57M.
- Annovis Bio, Inc. stock issued during period, value, new issues for fiscal 2023 was $14.44M.
- Annovis Bio, Inc. stock issued during period, value, new issues for fiscal 2021 was $46.65M, a 290.17% increase from fiscal 2020.
- Annovis Bio, Inc. stock issued during period, value, new issues for fiscal 2020 was $11.96M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-09-30 | $4.94M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $5.03M 10-Q · filed 2024-11-08 | |
| 2024-03-31 | $3.88M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $14.44M 10-K · filed 2024-03-29 | |
| 2023-06-30 | $8.57M 10-Q · filed 2024-11-08 | |
| 2021-12-31 | $46.65M 10-K · filed 2023-03-31 | |
| 2021-06-30 | $46.67M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $11.96M 10-K · filed 2022-03-02 | |
| 2020-03-31 | $11.96M 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |